VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CLOV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CLOVClover Health Investments, Corp.
$5.31$2.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCLOVQuarterly Financials

Clover Health Investments, Corp. (CLOV) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Clover Health Investments, Corp. (CLOV) quarterly income statement — complete revenue, gross profit & net income history

CLOV Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue744.19M487.71M496.65M477.62M462.33M336.96M330.99M356.26M346.92M510.25M306.03M320.14M321.99M898.79M856.82M846.7M874.38M432.04M427.16M412.47M
Revenue Growth %60.96%44.74%50.05%34.06%33.27%-33.96%8.16%11.28%7.74%-43.23%-64.28%-62.19%-63.17%108.04%100.58%105.27%336.48%159.9%152.66%139.7%
Cost of Goods Sold--------------------
COGS % of Revenue--------------------
Gross Profit154.54M74.21M73.18M99.63M108.89M93.92M81.21M107.91M81.76M62.27M70.24M75.88M47.2M5.15M17.02M-12.09M12.66M-9.77M-9.16M-46.03M
Gross Margin %20.77%15.22%14.73%20.86%23.55%27.87%24.54%30.29%23.57%12.2%22.95%23.7%14.66%0.57%1.99%-1.43%1.45%-2.26%-2.14%-11.16%
Gross Profit Growth %41.93%-20.99%-9.89%-7.68%33.18%50.84%15.62%42.22%73.21%1109.99%312.76%727.8%272.94%152.69%285.75%73.74%189.8%26.61%-137.82%-187.32%
Operating Expenses132.21M123.53M97.55M110.19M110.16M115.37M90M100.73M104.46M127.93M103.86M104.76M126.9M112.31M91.11M90.64M100.14M177.02M140.09M135.83M
OpEx % of Revenue17.77%25.33%19.64%23.07%23.83%34.24%27.19%28.27%30.11%25.07%33.94%32.72%39.41%12.5%10.63%10.71%11.45%40.97%32.8%32.93%
Selling, General & Admin0-140.31M97.15M109.79M109.7M115.02M90.2M99.92M103.79M109.93M101.6M104.15M126.63M124.35M117.97M117.53M126.79M114.21M119.21M107.81M
SG&A % of Revenue--28.77%19.56%22.99%23.73%34.14%27.25%28.05%29.92%21.54%33.2%32.53%39.33%13.84%13.77%13.88%14.5%26.43%27.91%26.14%
Research & Development--------------------
R&D % of Revenue--------------------
Other Operating Expenses--------------------
Operating Income22.33M-49.32M-24.38M-10.56M-1.27M-21.45M-8.79M7.19M-22.7M-65.66M-33.62M-28.88M-79.7M-107.16M-74.1M-102.73M-87.48M-186.79M-149.25M-181.86M
Operating Margin %3%-10.11%-4.91%-2.21%-0.28%-6.37%-2.65%2.02%-6.54%-12.87%-10.98%-9.02%-24.75%-11.92%-8.65%-12.13%-10%-43.23%-34.94%-44.09%
Operating Income Growth %1853.06%-129.95%-177.48%-246.92%94.39%67.33%73.87%124.88%71.51%38.73%54.63%71.88%8.9%42.63%50.36%43.51%26.54%-176.2%-590.41%-884.9%
EBITDA22.85M-48.9M-23.97M-10.16M-808K-21.1M-8.45M7.52M-22.39M-64.99M-33.06M-27.88M-79.42M-108M-73.48M-102.14M-86.66M-185.94M-149.13M-181.74M
EBITDA Margin %3.07%-10.03%-4.83%-2.13%-0.17%-6.26%-2.55%2.11%-6.45%-12.74%-10.8%-8.71%-24.66%-12.02%-8.58%-12.06%-9.91%-43.04%-34.91%-44.06%
EBITDA Growth %2927.85%-131.7%-183.81%-235.23%96.39%67.53%74.45%126.96%71.81%39.83%55.01%72.7%8.35%41.91%50.73%43.8%27.14%-175.52%-594.29%-879.25%
D&A (Non-Cash Add-back)515K420K406K394K466K344K339K330K318K674K557K999K279K-841K616K586K826K848K120K118K
EBIT27.33M-49.32M-24.38M-10.58M-1.27M-21.48M-8.79M7.17M-22.35M-70.47M-33.62M-28.88M-77.89M-83.91M-75.08M-103.95M-75.09M-186.79M-34.1M-316.37M
Net Interest Income00000000000-7K0-139K-413K-408K-403K-412K-426K-1.24M
Interest Income00000000000000000000
Interest Expense000000000007K0139K413K408K403K412K426K1.24M
Other Income/Expense--------------------
Pretax Income27.33M-49.32M-24.38M-10.58M-1.27M-21.48M-8.79M7.17M-23.17M-70.47M-33.62M-28.89M-79.7M-84.05M-75.49M-104.36M-75.49M-187.2M-34.53M-317.61M
Pretax Margin %3.67%-10.11%-4.91%-2.21%-0.28%-6.37%-2.65%2.01%-6.68%-13.81%-10.98%-9.02%-24.75%-9.35%-8.81%-12.33%-8.63%-43.33%-8.08%-77%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income27.33M-49.32M-24.38M-10.58M-1.27M-22.09M-9.15M7.41M-19.17M-70.47M-41.47M-28.81M-72.61M-84.05M-75.49M-104.36M-75.49M-187.2M-34.53M-317.61M
Net Margin %3.67%-10.11%-4.91%-2.21%-0.28%-6.56%-2.77%2.08%-5.53%-13.81%-13.55%-9%-22.55%-9.35%-8.81%-12.33%-8.63%-43.33%-8.08%-77%
Net Income Growth %2245.53%-123.25%-166.27%-242.79%93.35%68.65%77.92%125.71%73.6%16.15%45.07%72.39%3.82%55.1%-118.64%67.14%-55.92%-48.11%-370.63%-5978.42%
Net Income (Continuing)27.33M-49.32M-24.38M-10.58M-1.27M-21.48M-8.79M7.17M-23.17M-70.47M-33.62M-28.89M-79.7M-84.05M-75.49M-104.36M-75.49M-187.2M-34.53M-317.61M
Discontinued Operations00000-611K-370K238K1000K0-1000K75K1000K0000000
Minority Interest000000000000000003.9M3.9M3.9M
EPS (Diluted)0.05-0.10-0.05-0.02-0.00-0.04-0.020.01-0.04-0.15-0.09-0.06-0.15-0.18-0.16-0.22-0.16-0.40-0.08-0.78
EPS Growth %--112.47%-154.01%-308%93.5%70.07%79.22%116.67%73.33%16.67%43.75%72.73%6.25%55%-94.88%71.79%-23.08%-102.94%-360.63%-
EPS (Basic)0.05-0.10-0.05-0.02-0.00-0.04-0.020.01-0.04-0.15-0.09-0.06-0.15-0.18-0.16-0.22-0.16-0.40-0.08-0.78
Diluted Shares Outstanding522.18M517.24M512.74M508.89M497.06M491.87M490.18M495.18M567.45M481.61M480.77M479.16M478.81M477.9M477.69M476.06M473.03M470.85M420.63M408.31M
Basic Shares Outstanding522.18M517.24M512.74M508.89M497.06M491.87M490.18M487.48M486.37M481.61M480.77M479.16M478.81M477.9M477.69M476.06M473.03M470.85M420.63M408.31M
Dividend Payout Ratio--------------------